OKYO Pharma Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -47.6% | +0.4% | -18.8% | +100.0% | -83.3% | +126.8% | +45.8% | -30.6% | +0.0% | -31.3% | +5.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -38.8% | +199,899.6% | -100.0% | +100.0% | -69.6% | +200,069.2% | -100.0% | +199,853.1% | +0.0% | +14.8% | +4,106.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -38.8% | +378,421.6% | -100.0% | +100.0% | -69.6% | +271,587.8% | -100.0% | +21,786,803.0% | +0.0% | -33.2% | +129.4% | |
| – | – | – | – | – | – | – | – | -250,550.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -4.4% | -29.4% | +322.7% | |
| – | – | – | – | – | – | – | – | -189,182.8% | – | – | – | |
| – | – | +199,875.9% | -100.0% | +100.0% | -1,272.0% | – | – | -260,826.3% | – | – | +15,159.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.